You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 247 No. 8, February 26, 1982 TABLE OF CONTENTS
  JAMA
  •  Online Features
  BRIEF REPORTS
 This Article
 •References
 •Full text PDF
 •Correction
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Stimulant Medications Precipitate Tourette's Syndrome

Thomas L. Lowe, MD; Donald J. Cohen, MD; Jill Detlor, RN; Martin W. Kremenitzer, MD; Bennett A. Shaywitz, MD

JAMA. 1982;247(8):1168-1169.


Abstract

Following treatment with stimulant medications for symptoms of attention deficit disorder, Gilles de la Tourette's syndrome occurred in 15 patients. Early signs of Tourette's syndrome may be difficult to distinguish from hyperactive and attention disordered symptoms, leading the clinician to consider treatment with stimulants. In these Tourette's-susceptible patients, stimulants may exacerbate severe motor and phonic tics, requiring discontinuation of administration of stimulants and institution of haloperidol therapy for tic control. Clinical evaluation for tics and Tourette's syndrome in children and their families should precede and dictate use of stimulant medications in children.

(JAMA 1982;247:1168-1169)



Author Affiliations

From the Child Study Center and Department of Psychiatry (Drs Lowe and Cohen and Ms Detlor), the Department of Pediatrics (Drs Lowe, Cohen, and Shaywitz), and the Department of Neurology (Drs Kremenitzer and Shaywitz), Yale University School of Medicine, New Haven, Conn. Dr Lowe is presently with the Department of Psychiatry, University of South Florida College of Medicine, Tampa.


Footnotes

Reprint requests to Child Study Center, 333 Cedar St, New Haven, CT 06510 (Dr Cohen).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

A Randomized, Double-Blind, Placebo-Controlled Study of Guanfacine Extended Release in Children and Adolescents With Attention-Deficit/Hyperactivity Disorder
Biederman et al.
Pediatrics 2008;121:e73-e84.
ABSTRACT | FULL TEXT  

Atomoxetine treatment in children and adolescents with ADHD and comorbid tic disorders
Allen et al.
Neurology 2005;65:1941-1949.
ABSTRACT | FULL TEXT  

Childhood Caffeine Tic Syndrome
Davis and Osorio
Pediatrics 1998;101 :e4-e4.
ABSTRACT | FULL TEXT  

Tourette's Syndrome Precipitated by Phenytoin
CLIN PEDIATR 1985;24:323-323.
 

Treatment of Gilles de la Tourette's Syndrome With Clonidine and Neuroleptics
Shapiro et al.
Arch Gen Psychiatry 1983;40:1235-1240.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1982 American Medical Association. All Rights Reserved.